SCIENSUS PHARMA SERVICES LIMITED - Profile & Financials

Accounts Submitted 20 Oct 2025

Confirmation Statement Submitted 16 Jul 2025

Net assets £43.23M £10.46M 2024 year on year

Total assets £458.88M £19.48M 2024 year on year

Total Liabilities £415.65M £29.94M 2024 year on year

Charges 17

2 outstanding 15 satisfied

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

20 Eastbourne Terrace London W2 6LG England

Office (Slough)

1 London Rd, Slough SL3 7FJ

Office (Head Office)

107 Station Street, Burton upon Trent, Staffordshire, DE14 1SZ, UK

Office (Pharmacy)

Fifth Avenue, Centrum 100, BURTON-ON-TRENT, Staffordshire, DE14 2WS, UK

Office (Pharmacy)

Plot 7, Junction Close, Green Lane Industrial Park, Featherstone, PONTEFRACT, West Yorkshire, WF7 6TA, UK

Telephone

0333 103 9499

comms@hah.co.uk

Website

medihome.co.uk

Credit Report

Discover SCIENSUS PHARMA SERVICES LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£1.11M

Increased by £68.00k (+6%)

Net Assets

£43.23M

Decreased by £10.46M (-19%)

Total Liabilities

£415.65M

Increased by £29.94M (+8%)

Turnover

£1599.23M

Decreased by £60.37M (-4%)

Employees

1325

Decreased by 348 (-21%)

Debt Ratio

91%

Increased by 3 (+3%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

5 active 31 resigned

Show resigned officers

						Status
Christian Tucat	Director	Italian	England	56	19 Nov 2024	Active
Francesca Geretto	Director	Italian	England	48	18 Oct 2024	Active
John Bradshaw	Secretary	Unknown	Unknown	—	4 Dec 2013	Active
John Richard Bradshaw	Director	British	England	70	4 Dec 2013	Active
Jonathan Elliott Asbridge	Director	British	England	67	28 Jul 2016	Active

Shareholders

Shareholders (4)


Halcyon Acquisitions Ltd	45.1%	226	B Ordinary	27 Jun 2022
Halcyon Acquisitions Ltd	39.9%	200	C Ordinary	27 Jun 2022
Halcyon Acquisitions Ltd	0.0%	0	Preference	27 Jun 2022

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Halcyon Acquisitions Limited

Unknown

Active

Notified 26 Oct 2020

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors

Egx Group Limited

Ceased 26 Oct 2020

Ceased

See All Controllers

Group Structure

HALCYON ACQUISITIONS LIMITED united kingdom shares 75 to 100 percent

HALCYON FINANCING LIMITED united kingdom shares 75 to 100 percent

HALCYON MIDCO LIMITED united kingdom shares 75 to 100 percent

HALCYON TOPCO LIMITED united kingdom shares 75 to 100 percent as trust

VITRUVIAN PARTNERS LLP united kingdom

SCIENSUS PHARMA SERVICES LIMITED Current Company

HEALTHCARE AT HOME LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

HOSPITAL AT HOME LIMITED united kingdom shares 75 to 100 percent

MEDIHOME LIMITED united kingdom shares 75 to 100 percent

PHARMASERVICE LIMITED united kingdom shares 75 to 100 percent

REFER2US UK LIMITED united kingdom shares 75 to 100 percent

SCIENSUS2 LIMITED united kingdom shares 75 to 100 percent

SCIENSUS LOGISTICS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

SCIENSUS LTD united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

TELECARE LIMITED united kingdom shares 75 to 100 percent

VINEHEALTH DIGITAL LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

Charges

2 outstanding 15 satisfied

Documents

Company Filings

Date	Category	Description	Document
14 Nov 2025	Officers	Termination of Francesca Geretto as director on 2025-11-14	View(1 page)
20 Oct 2025	Accounts	Annual accounts made up to 2026-03-31	View(1 page)
29 Sept 2025	Mortgage	Mortgage Satisfy Charge Full	View(1 page)
16 Jul 2025	Confirmation Statement	Confirmation statement made on 2025-06-27 with no updates	View(3 pages)
10 Jul 2025	Accounts	Annual accounts made up to 2025-03-31	View(54 pages)